Education
About Us
Working with TipRanks
Follow Us
Rocket Pharma (DE:9IP1)
:9IP1
Rocket Pharmaceuticals (9IP1) Ownership Overview
35.23% Insiders
22.38% Mutual Funds
8.05% Other Institutional Investors
12.25% ETFs
22.09% Public Companies and Individual Investors
The ownership structure of Rocket Pharmaceuticals (DE:9IP1) stock is a mix of institutional, retail, and individual investors. Approximately 42.68% of the company’s stock is owned by Institutional Investors, 35.23% is owned by Insiders, and 22.09% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 27, 2025 | John Militello Vp Of Finance, Treasurer, Principal Accounting Officer | xxxxxxxxxxxxx | $9300 |
| Nov 25, 2024 | John Militello Vp Of Finance, Treasurer, Principal Accounting Officer | xxxxxxxxxxxxx | $15973 |
| Nov 25, 2024 | Kinnari Patel President, Head Of R&d And Coo | xxxxxxxxxxxxx | $59873 |
| Nov 25, 2024 | Gaurav Shah Ceo,director | xxxxxxxxxxxxx | $144738 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $313030 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1220283 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $4758800 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $8200931 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,157,605 | Insider | 17.08% | 172,243,041 | |
| 16,272,635 | Insider | 15.30% | 154,362,216 | |
| 6,490,225 | Institution | 6.10% | 61,566,274 | |
| 6,257,876 | Institution | 5.88% | 59,362,212 | |
| 4,622,076 | Institution | 4.35% | 43,845,013 | |
| 4,118,672 | Institution | 3.87% | 39,069,723 | |
| 3,416,478 | Institution | 3.21% | 32,408,710 | |
| 1,857,382 | Institution | 1.75% | 17,619,126 | |
| 1,195,221 | Insider | 1.12% | 11,337,866 | |
| 1,053,860 | Institution | 0.99% | 9,996,916 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,490,225 | Institution | 6.10% | 61,566,274 | |
| 4,622,076 | Institution | 4.35% | 43,845,013 | |
| 1,053,860 | Institution | 0.99% | 9,996,916 | |
| 1,044,279 | Institution | 0.98% | 9,906,031 | |
| 1,008,397 | Institution | 0.95% | 9,565,654 | |
| 770,691 | Institution | 0.72% | 7,310,775 | |
| 718,153 | Institution | 0.68% | 6,812,399 | |
| 717,463 | Institution | 0.67% | 6,805,854 | |
| 690,270 | Institution | 0.65% | 6,547,901 | |
| 580,600 | Institution | 0.55% | 5,507,572 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Rocket Pharma (DE:9IP1)?
According to the latest TipRanks data, approximately 8.05% of the company's stock is held by institutional investors, 35.23% is held by insiders, and 22.09% is held by retail investors.
What percentage of Rocket Pharma (DE:9IP1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 8.05% of Rocket Pharma (DE:9IP1) stock is held by institutional investors.
What percentage of Rocket Pharma (DE:9IP1) stock is held by retail investors?
According to the latest TipRanks data, approximately 22.09% of Rocket Pharma (DE:9IP1) stock is held by retail investors.
Who owns the most shares of Rocket Pharma (DE:9IP1)?
RTW INVESTMENTS, LP owns the most shares of Rocket Pharma (DE:9IP1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.